vs
Side-by-side financial comparison of Organon & Co. (OGN) and Primerica, Inc. (PRI). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $853.7M, roughly 1.8× Primerica, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs -13.6%, a 36.7% gap on every dollar of revenue. On growth, Primerica, Inc. posted the faster year-over-year revenue change (11.0% vs -5.3%). Over the past eight quarters, Primerica, Inc.'s revenue compounded faster (7.2% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.
OGN vs PRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $853.7M |
| Net Profit | $-205.0M | $197.0M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 28.9% |
| Net Margin | -13.6% | 23.1% |
| Revenue YoY | -5.3% | 11.0% |
| Net Profit YoY | -288.1% | 17.9% |
| EPS (diluted) | $-0.78 | $6.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $853.7M | ||
| Q3 25 | $1.6B | $839.9M | ||
| Q2 25 | $1.6B | $793.3M | ||
| Q1 25 | $1.5B | $804.8M | ||
| Q4 24 | $1.6B | $768.8M | ||
| Q3 24 | $1.6B | $774.1M | ||
| Q2 24 | $1.6B | $803.4M | ||
| Q1 24 | $1.6B | $742.8M |
| Q4 25 | $-205.0M | $197.0M | ||
| Q3 25 | $160.0M | $206.8M | ||
| Q2 25 | $145.0M | $178.3M | ||
| Q1 25 | $87.0M | $169.1M | ||
| Q4 24 | $109.0M | $167.1M | ||
| Q3 24 | $359.0M | $164.4M | ||
| Q2 24 | $195.0M | $1.2M | ||
| Q1 24 | $201.0M | $137.9M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | 98.0% | ||
| Q1 24 | 59.0% | 98.2% |
| Q4 25 | -9.8% | 28.9% | ||
| Q3 25 | 15.2% | 32.3% | ||
| Q2 25 | 14.4% | 29.6% | ||
| Q1 25 | 6.7% | 27.5% | ||
| Q4 24 | 8.1% | 64.7% | ||
| Q3 24 | 13.1% | 32.9% | ||
| Q2 24 | 14.6% | 1.0% | ||
| Q1 24 | 14.5% | 24.1% |
| Q4 25 | -13.6% | 23.1% | ||
| Q3 25 | 10.0% | 24.6% | ||
| Q2 25 | 9.1% | 22.5% | ||
| Q1 25 | 5.8% | 21.0% | ||
| Q4 24 | 6.8% | 21.7% | ||
| Q3 24 | 22.7% | 21.2% | ||
| Q2 24 | 12.1% | 0.1% | ||
| Q1 24 | 12.4% | 18.6% |
| Q4 25 | $-0.78 | $6.11 | ||
| Q3 25 | $0.61 | $6.35 | ||
| Q2 25 | $0.56 | $5.40 | ||
| Q1 25 | $0.33 | $5.05 | ||
| Q4 24 | $0.42 | $4.92 | ||
| Q3 24 | $1.38 | $4.83 | ||
| Q2 24 | $0.75 | $0.03 | ||
| Q1 24 | $0.78 | $3.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $756.2M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $2.4B |
| Total Assets | $12.9B | $15.0B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $756.2M | ||
| Q3 25 | $672.0M | $644.9M | ||
| Q2 25 | $599.0M | $621.2M | ||
| Q1 25 | $547.0M | $625.1M | ||
| Q4 24 | $675.0M | $687.8M | ||
| Q3 24 | $763.0M | $550.1M | ||
| Q2 24 | $704.0M | $627.3M | ||
| Q1 24 | $575.0M | $593.4M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $2.4B | ||
| Q3 25 | $906.0M | $2.3B | ||
| Q2 25 | $733.0M | $2.3B | ||
| Q1 25 | $542.0M | $2.3B | ||
| Q4 24 | $472.0M | $2.3B | ||
| Q3 24 | $493.0M | $1.9B | ||
| Q2 24 | $144.0M | $2.1B | ||
| Q1 24 | $48.0M | $2.2B |
| Q4 25 | $12.9B | $15.0B | ||
| Q3 25 | $13.6B | $14.8B | ||
| Q2 25 | $13.5B | $14.8B | ||
| Q1 25 | $13.2B | $14.6B | ||
| Q4 24 | $13.1B | $14.6B | ||
| Q3 24 | $12.8B | $14.8B | ||
| Q2 24 | $12.2B | $14.6B | ||
| Q1 24 | $11.9B | $14.9B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $338.2M |
| Free Cash FlowOCF − Capex | $96.0M | — |
| FCF MarginFCF / Revenue | 6.4% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $338.2M | ||
| Q3 25 | $264.0M | $202.9M | ||
| Q2 25 | $220.0M | $162.6M | ||
| Q1 25 | $75.0M | $197.5M | ||
| Q4 24 | $390.0M | $270.6M | ||
| Q3 24 | $141.0M | $207.3M | ||
| Q2 24 | $332.0M | $173.3M | ||
| Q1 24 | $76.0M | $210.9M |
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 2.8% | — |
| Q4 25 | — | 1.72× | ||
| Q3 25 | 1.65× | 0.98× | ||
| Q2 25 | 1.52× | 0.91× | ||
| Q1 25 | 0.86× | 1.17× | ||
| Q4 24 | 3.58× | 1.62× | ||
| Q3 24 | 0.39× | 1.26× | ||
| Q2 24 | 1.70× | 147.98× | ||
| Q1 24 | 0.38× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |
